Amanote Research
Register
Sign In
Targeted Therapy for Renal Cell Carcinoma
doi 10.2217/ebo.11.63
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2011
Authors
Ronald M Bukowski
Publisher
Future Medicine Ltd
Related search
Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population
Clinical Genitourinary Cancer
Oncology
Urology
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Clinical Genitourinary Cancer
Oncology
Urology
Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma
Seminars in Nephrology
Nephrology
Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents
Current Oncology
Oncology
Adjuvant Therapy After Nephrectomy for Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy
Kidney International
Nephrology
Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma
Progress in Tumor Research
Cancer Research
Oncology
Targeted Therapy for the Loss of Von Hippel-Lindau in Renal Cell Carcinoma: A Novel Molecule That Induces Autophagic Cell Death
Autophagy
Cell Biology
Molecular Biology